• Episode 20 - KINECT-HD with Dr. Dietrich Haubenberger

  • Sep 24 2020
  • Length: 47 mins
  • Podcast

Episode 20 - KINECT-HD with Dr. Dietrich Haubenberger

Listen for free

View show details

  • Summary

  • Dr. Dietrich Haubenberger, Medical Director at Neurocrine Biosciences, joined the HD Insights Podcast to talk about his work on the KINECT-HD study and his career journey to this point. KINECT-HD is a Phase 3, randomized, double-blind, placebo-controlled study investigating valbenazine for treatment of chorea in Huntington disease. The study is being conducted at sites across the U.S. and Canada. Additional information about the study can be found at www.KINECT-HD.org.

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Show more Show less

What listeners say about Episode 20 - KINECT-HD with Dr. Dietrich Haubenberger

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available